Editorial: Safety and efficacy of antivirals against SARS-CoV-2 – “we need evidence not optimism”.
31 Oct, 2021 | 20:11h | UTCSafety and efficacy of antivirals against SARS-CoV-2 – The BMJ
Commentary on Twitter
"Effective antivirals have an obvious appeal, but this must not cloud objective and transparent decision making." @dpsg108 and colleagues on the government's stockpiling of molnupiravir and PF-07321332+ritonavir for covid-19https://t.co/JUj1Y9op3P
— The BMJ (@bmj_latest) October 28, 2021